Ultrasound molecular imaging based on TM carrying anti‐VCAM‐1 polypeptide can provide a sensitive and specific technique to achieve early warning of AKI, thus guiding the treatment of AKI promptly and improving its prognosis. This evidence concerns the gene VCAM1 and acute kidney injury.